PL2651409T3 - Nowa kompozycja farmaceutyczna zawierająca nlpz i cyklodekstrynę - Google Patents

Nowa kompozycja farmaceutyczna zawierająca nlpz i cyklodekstrynę

Info

Publication number
PL2651409T3
PL2651409T3 PL11805146T PL11805146T PL2651409T3 PL 2651409 T3 PL2651409 T3 PL 2651409T3 PL 11805146 T PL11805146 T PL 11805146T PL 11805146 T PL11805146 T PL 11805146T PL 2651409 T3 PL2651409 T3 PL 2651409T3
Authority
PL
Poland
Prior art keywords
cyclodecstrin
pharmaceutical composition
composition containing
new pharmaceutical
containing nsaids
Prior art date
Application number
PL11805146T
Other languages
English (en)
Inventor
Edward Beech
Alden Rodwell
Mark Squires
Original Assignee
Reckitt Benckiser Healthcare International Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare International Limited filed Critical Reckitt Benckiser Healthcare International Limited
Publication of PL2651409T3 publication Critical patent/PL2651409T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Nanotechnology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL11805146T 2010-12-15 2011-12-12 Nowa kompozycja farmaceutyczna zawierająca nlpz i cyklodekstrynę PL2651409T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1021267.8A GB201021267D0 (en) 2010-12-15 2010-12-15 Novel pharmaceutical formulation
EP11805146.5A EP2651409B1 (en) 2010-12-15 2011-12-12 Novel pharmaceutical formulation comprising nsaid and cyclodextrin

Publications (1)

Publication Number Publication Date
PL2651409T3 true PL2651409T3 (pl) 2017-05-31

Family

ID=43567237

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11805146T PL2651409T3 (pl) 2010-12-15 2011-12-12 Nowa kompozycja farmaceutyczna zawierająca nlpz i cyklodekstrynę

Country Status (14)

Country Link
US (2) US9138482B2 (pl)
EP (1) EP2651409B1 (pl)
KR (2) KR20130141555A (pl)
CN (1) CN103260617B (pl)
AU (1) AU2011343030B2 (pl)
BR (1) BR112013014833B1 (pl)
ES (1) ES2602128T3 (pl)
GB (2) GB201021267D0 (pl)
MX (1) MX343035B (pl)
PL (1) PL2651409T3 (pl)
RU (1) RU2607592C2 (pl)
TW (1) TWI526205B (pl)
WO (1) WO2012080718A1 (pl)
ZA (1) ZA201303261B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201021267D0 (en) * 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation
GB201215988D0 (en) 2012-09-07 2012-10-24 Reckitt Benckiser Healthcare Int Ltd Pharmaceutical compositions comprising flurbiprofen
EP3193879A4 (en) * 2014-09-17 2018-05-16 Epizyme, Inc. Injectable formulations for treating cancer
GB2569940B (en) 2017-11-01 2022-10-19 Nicoventures Trading Ltd Aerosolisable formulation
KR102545748B1 (ko) * 2017-12-26 2023-06-21 한미약품 주식회사 플루르비프로펜 함유 스프레이 조성물 및 그 제조방법
CN111494307A (zh) * 2019-01-30 2020-08-07 北京普德康利医药科技发展有限公司 一种氟比洛芬注射液
GB2581344B (en) * 2019-02-11 2023-05-24 Reckitt Benckiser Health Ltd Novel composition
MY209611A (en) * 2019-02-11 2025-07-24 Reckitt Benckiser Health Ltd Novel composition
CN110283259B (zh) * 2019-07-03 2021-12-10 宁夏医科大学 一种解热镇痛布洛芬-β-环糊精第一面衍生物及其制备方法
EP4121417A4 (en) * 2020-05-01 2023-08-09 University Of Southern California CYCLODEXTRIN-BASED ANTIMICROBIAL THERAPY
CN116602942A (zh) * 2023-06-16 2023-08-18 贵州联盛药业有限公司 一种氟比洛芬凝胶贴膏及其制备方法
CN116870231A (zh) * 2023-08-03 2023-10-13 北京化工大学常州先进材料研究院 一种纳米纤维敷料

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5634618A (en) 1979-08-30 1981-04-06 Ota Seiyaku Kk Production of flurbiprofen preparation
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5024997A (en) * 1990-06-22 1991-06-18 American Home Products Corporation Palatable ibuprofen solutions
IT1243342B (it) 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
DE4038314A1 (de) 1990-11-30 1992-06-04 Puetter Medice Chem Pharm Komplexe des aktiven enantiomers des ibuprofens mit cyclodextrin
GB9316580D0 (en) * 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
GB9318880D0 (en) * 1993-09-11 1993-10-27 Smithkline Beecham Plc Pharmaceutical composition
AU7637296A (en) 1995-11-14 1997-06-05 Farmarc Nederland Bv Complex of naproxen and beta-cyclodextrin
GB9523833D0 (en) 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
WO1998052540A1 (en) 1997-05-22 1998-11-26 The Boots Company Plc Pharmaceutical compositions
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
EP1567126A2 (en) * 2002-11-27 2005-08-31 Pharmacia Corporation Concentrated liquid valdecoxib composition
CZ295151B6 (cs) * 2004-02-20 2005-06-15 I. Q. A., A. S. Stabilní, chuťově přijatelné sirupy obsahující ibuprofen a způsob jejich přípravy
JP2007528384A (ja) * 2004-03-10 2007-10-11 シモダ、バイオテック(プロプライエタリー)リミテッド 安定な注射可能なジクロフェナク組成物
US20060120967A1 (en) * 2004-12-07 2006-06-08 Qpharma, Llc Solution forms of cyclodextrins for nasal or throat delivery of essential oils
KR20090010953A (ko) * 2006-03-28 2009-01-30 자블린 파머슈티칼스 인코포레이티드 저 복용량의 비-스테로이드성 항염증성 약물 및 베타-사이클로덱스트린 제형
EP1974751A1 (en) 2007-03-26 2008-10-01 The Jordanian Pharmaceutical Manufacturing Co. Formulations for non-steroidal anti-inflammatory drugs
WO2009089269A1 (en) * 2008-01-07 2009-07-16 Javelin Pharmaceuticals, Inc. Methods of treating pain while minimizing adverse effects on platelet function
CN101559077A (zh) * 2009-04-16 2009-10-21 官培龙 一种口腔炎症性疾病止痛用含漱液
GB201021267D0 (en) * 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation

Also Published As

Publication number Publication date
ES2602128T3 (es) 2017-02-17
KR102013718B1 (ko) 2019-08-23
MX2013006644A (es) 2013-08-09
EP2651409A1 (en) 2013-10-23
US9138482B2 (en) 2015-09-22
ZA201303261B (en) 2014-07-30
GB201021267D0 (en) 2011-01-26
RU2013132210A (ru) 2015-01-27
RU2607592C2 (ru) 2017-01-10
TW201231048A (en) 2012-08-01
KR20180110184A (ko) 2018-10-08
CN103260617A (zh) 2013-08-21
US20140296342A1 (en) 2014-10-02
GB2486567B (en) 2014-09-10
US10363316B2 (en) 2019-07-30
KR20130141555A (ko) 2013-12-26
BR112013014833B1 (pt) 2022-09-20
GB201121476D0 (en) 2012-01-25
CN103260617B (zh) 2016-08-24
AU2011343030A1 (en) 2013-05-30
US20160008478A1 (en) 2016-01-14
GB2486567A (en) 2012-06-20
BR112013014833A2 (pt) 2018-05-15
AU2011343030B2 (en) 2017-03-30
EP2651409B1 (en) 2016-08-10
WO2012080718A1 (en) 2012-06-21
TWI526205B (zh) 2016-03-21
MX343035B (es) 2016-10-21

Similar Documents

Publication Publication Date Title
PL2651409T3 (pl) Nowa kompozycja farmaceutyczna zawierająca nlpz i cyklodekstrynę
SMT201700008B (it) Composizione farmaceutica
DK3246018T3 (da) Farmaceutisk sammensætning
IL257518B (en) Integrin agonist compounds and medicinal compositions thereof
SMT201600350B (it) Composizioni farmaceutiche
HRP20160579T1 (hr) Spoj indola i njegova farmaceutska upotreba
BR112012031855A2 (pt) composição e artigo
DK2654736T3 (da) Hidtil ukendt farmaceutisk sammensætning
EE201300005A (et) Ravimkoostis
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
BR112015004936A2 (pt) composição farmacêutica revestida contendo regorafenib
BR112013014644A2 (pt) composição farmacêutica e complexo
BR112012027165A2 (pt) composição e artigo
LT2603232T (lt) Stabilios linaklotido vaisto formos
HRP20160922T1 (hr) Oligopeptidni spojevi i njihove uporabe
GT201200303A (es) Formulaciones farmacéuticas
DK2542224T3 (da) Oral farmaceutisk sammensætning indeholdende dabigatranetexilat
EP2642979A4 (en) PHARMACEUTICAL COMPOSITION
BR112013010074A2 (pt) composição celulósica e produto
DK3156060T3 (da) Farmaceutiske sammensætninger og topisk anvendelse deraf
CO6801722A2 (es) Composiciones farmacéuticas
FR2958537B1 (fr) Composition dentaire
SMT201500005B (it) Composizione framaceutica inalabile
BR112015002646A2 (pt) composto e composição farmacêutica
BR112012029461A2 (pt) composição farmacêutica contendo solifenacina